December 15, 2020
HHS purchases 100 million additional doses of Moderna’s COVID-19 vaccine
Editor's Note
The Department of Health and Human Services (HHS) announced on December 11 that it would purchase 100 million additional doses of Moderna’s COVID-19 vaccine.
The vaccine, which was developed by Moderna with scientists from the National Institute of Allergy and Infectious Diseases (NIAID), is scheduled for a December 17 review by the Food and Drug Administration. Anthony Fauci, MD, is director of NIAID.
The purchase doubles the amount of Moderna vaccine owned by the federal government to 200 million.
Free Daily News
- AI is transforming nursing practice but demands stronger ethics, training
- Government shutdown stalls healthcare access, freezes Medicare telehealth, hospital-at-home services
- ACS launches hospital search tool to spotlight surgical quality
- Higher MAP targets in acute spinal cord injury show no neurologic benefit, more complications
- Sports medicine procedures cost far less in ASCs than HOPDs
- Bariatric surgery outpaces GLP-1s in weight loss, cost savings
- Study finds overweight older adults have lower postsurgical mortality than peers with normal BMI
- FDA posts four device safety communications, prompting inventory, workflow checks
- 7 strategies healthcare leaders can use to turn around toxic workplace culture
- Nutrition screening tool predicts poor outcomes after pancreatic cancer surgery
© Access Intelligence, LLC. All rights reserved. |
Privacy Policy |
Cookie Settings |
Diversity, Equity, Inclusion & Belonging |
Accessibility Statement